Foamy virus as a gene transfer vector to the central nervous system

Gene Therapy

Volumn 16, Issue 3, 2009, Pages 448-452

  Caprariello, A V ^a   Miller, R H ^a   Selkirk, S M ^b  

^a CASE WESTERN RESERVE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b LOUIS STOKES CLEVELAND VA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BROXURIDINE; FOAMY VIRUS VECTOR; UNCLASSIFIED DRUG; VIRUS VECTOR;

ANIMAL EXPERIMENT; ARTICLE; BRAIN TISSUE; CELL CYCLE; CONTROLLED STUDY; DATA ANALYSIS; GENE TARGETING; GENETIC ENGINEERING; IN VIVO STUDY; LENTIVIRINAE; NONHUMAN; PRIORITY JOURNAL; RAT; RETROVIRUS; SPUMA VIRUS; VIRAL GENE DELIVERY SYSTEM; VIRUS TITRATION;

ANIMALS; BRAIN; CELL CYCLE; CELLS, CULTURED; GENE EXPRESSION REGULATION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; LENTIVIRUS; RATS; SPUMAVIRUS; TRANSDUCTION, GENETIC; TRANSGENES; VIRUS INTEGRATION;

HUMAN SPUMARETROVIRUS; LENTIVIRUS; RATTUS;

EID: 62549142250     PISSN: 09697128     EISSN: 14765462     Source Type: Journal    
DOI: 10.1038/gt.2008.171     Document Type: Article

References (19)

1. Trobridge G, Josephson N, Vassilopoulos G, Mac J, Russell DW. Improved foamy virus vectors with minimal viral sequences. Mol Ther 2002; 6: 321-328.
2. Hooks JJ, Gibbs Jr CJ. The foamy viruses. Bacteriol Rev 1975; 39: 169-185.
3. Schweizer M, Turek R, Hahn H, Schliephake A, Netzer KO, Eder G et al Markers of foamy virus infections in monkeys, apes, and accidentally infected humans: Appropriate testing fails to confirm suspected foamy virus prevalence in humans. AIDS Res Hum Retroviruses 1995; 11 161-170.
4. Flacone V, Schweizer M, Neumann-Haefelin D. Replication of primate foamy viruses in natural and experimental hosts. Curr Top Microbiol Immunol 2003; 277: 161-180.
5. Heneine W, Schweizer M, Sandsrtrom P, Folks T. Human infection with foamy viruses. Curr Top Microbiol Immunol 2003; 277: 181-196.
6. Yu SF, Baldwin DN, Gwynn WR, Yendapalli S, Linial ML. Human foamy virus replication: A pathway distinct from that of retrovirus and hepadnaviruses. Science 1996; 271: 1579-1582.
7. Saib A, Puvion-Dutilleul F, Schmid M, Peries J, The HD. Nuclear targeting of incoming human foamy virus Gag proteins involves a centriolar step. J Virol 1997; 71: 1155-1161.
8. Hacein-Bay-Abina S, von Kalle C, Schmidt M, Le Deist F, Wulffraat N, McIntyre E et al. A serious adverse event after successful gene therapy for X-linked severe combined immuno-deficiency. N Engl J Med 2003; 348: 255-256.
9. Schroder AR, Shinn P, Chen H, Berry C, Ecker JR, Bushman F. HIV-1 integration in the human genome favors active genes and local hotspots. Cell 2002; 110: 521-529.
10. Wu X, Li Y, Crise B, Burgess SM. Transcription start regions in the human genome are favored targets for MLV integration. Science 2003; 300: 1749-1751.
11. Trobridge GD, Miller DG, Jacobs MA, Allen JM, Kiem HP, Kaul R et al Foamy virus vector integration sites in normal human cells. Proc Natl Acad Sci USA 2006; 103: 1498-1503.
12. Josephson NC, Vassilopoulos G, Trobridge GD, Priestley GV, Wood BL, Papayannopoulou T et al. Transduction of human NOD/ SCID-repopulating cells with both lymphoid and myeloid potential by foamy virus vectors. Proc Natl Acad Sci USA 2002; 99: 8295-8300.
13. Liu W, He X, Cao Z, Sheng J, Liu H, Li Z et al. Efficient therapeutic gene expression in cultured rat hippocampal neurons mediated by human foamy virus vectors: A potential for the treatment of neurological diseases. Intervirology 2005; 48: 329-335.
14. Mergia A, Chari S, Kolson DL, Goodenow MM, Ciccarone T. The efficiency of simian foamy virus vector type-1 (SFV-1) in nondividing cells and in human PBLs. Virology 2001; 280: 243-252.
15. Kiem HP, Allen J, Trobridge G, Olson E, Keyser K, Peterson L et al Foamy-virus-mediated gene transfer to canine repopulating cells. Blood 2007; 109: 65-70.
16. Trobridge G, Russell DW. Cell cycle requirements for transduction by foamy virus vectors compared to those of oncovirus and lentivirus vectors. J Virol 2004; 78: 2327-2335.
17. Coleman JE, Huentelman MJ, Kasparov S, Metcalfe BL, Paton JFR, Katovich MJ et al. Efficient large-scale production and concentration of HIV-1-based lentiviral vectors for use in vivo. Physiol Genomics 2003; 12: 221-228.
18. Russell DW, Miller AD. Foamy virus vectors. J Virol 1996; 70 217-222.
19. Steffens S, Tebbets J, Kramm CM, Lindemann D, Flake A, Sena-Esteves M. Transduction of human glial and neuronal tumor cells with different lentiviral vector pseudotypes. J Neurooncol 2004; 70: 281-288.